Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(1S,2R,3S,4R,5R)-2,3,4-trihydroxy-N-octyl-6-oxa-8-azabicyclo[3.2.1]octane-8-carbothioamide
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
(1S,2R,3S,4R,5R)-2,3,4-trihydroxy-N-octyl-6-oxa-8‑azabicyclo[3.2.1]octane‑8‑carbothioamide is a synthetic small molecule belonging to the oxepanes class—compounds containing an oxepane ring structure with one oxygen and six carbon atoms in a seven-membered saturated aliphatic heterocycle[6][8]. It is described as a solid compound with the molecular formula C15H28N2O4S and a molecular weight of 332.5 g/mol[6]. The compound has been identified as targeting the protein beta-glucosidase A; however its pharmacological use or clinical indication is not established in public drug databases and it appears to be primarily of research interest at this time[6][8].
- Other names
- (1s,2r,3s,4r,5r)-2,3,4-Trihydroxy-N-Octyl-6-Oxa-8-Azabicyclo[3.2.1]octane-8-Carbothioamide(1S,2R,3S,4R,5R)-2,3,4-trihydroxy-N-octyl-6-oxa-8-azabicyclo(3.2.1)octane-8-carbothioamide
02
Targets
Glucocerebrosidase (GBA1)
Beyond the preview
Go deeper on (1S,2R,3S,4R,5R)-2,3,4-trihydroxy-N-octyl-6-oxa-8-azabicyclo[3.2.1]octane-8-carbothioamide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on (1S,2R,3S,4R,5R)-2,3,4-trihydroxy-N-octyl-6-oxa-8-azabicyclo[3.2.1]octane-8-carbothioamide.